Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies.

by Jasmine Foo, Franziska Michor
Published 2009-11-01

Evolutionary dynamics of intratumor heterogeneity.

by Yoh Iwasa, Franziska Michor
Published 2011-03-01

Patterns of proliferative activity in the colonic crypt determine crypt stability and rates of somatic evolution.

by Rui Zhao, Franziska Michor
Published 2013-01-01

Correction: Evolution of Resistance to Targeted Anti-Cancer Therapies during Continuous and Pulsed Administration Strategies.

by Jasmine Foo, Franziska Michor
Published 2009-12-01

Correction: (A)Symmetric Stem Cell Replication and Cancer.

by David Dingli, Arne Traulsen, Franziska Michor
Published 2007-04-01

A race between tumor immunoescape and genome maintenance selects for optimum levels of (epi)genetic instability.

by Shingo Iwami, Hiroshi Haeno, Franziska Michor
Published 2012-01-01

(A)symmetric stem cell replication and cancer.

by David Dingli, Arne Traulsen, Franziska Michor
Published 2007-03-01

On the validity of using increases in 5-year survival rates to measure success in the fight against cancer.

by Yosef E Maruvka, Min Tang, Franziska Michor
Published 2014-01-01

The therapeutic implications of plasticity of the cancer stem cell phenotype.

by Kevin Leder, Eric C Holland, Franziska Michor
Published 2010-12-01

Histone modifications are associated with transcript isoform diversity in normal and cancer cells.

by Ondrej Podlaha, Subhajyoti De, Mithat Gonen, Franziska Michor
Published 2014-06-01

Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients.

by Lin L Liu, Fei Li, William Pao, Franziska Michor
Published 2015-01-01

Stochastic Tunneling of Two Mutations in a Population of Cancer Cells.

by Hiroshi Haeno, Yosef E Maruvka, Yoh Iwasa, Franziska Michor
Published 2013-01-01

Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients.

by Shayna Stein, Rui Zhao, Hiroshi Haeno, Igor Vivanco, Franziska Michor
Published 2018-01-01

Estimating mono- and bi-phasic regression parameters using a mixture piecewise linear Bayesian hierarchical model.

by Rui Zhao, Paul Catalano, Victor G DeGruttola, Franziska Michor
Published 2017-01-01

Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.

by Jasmine Foo, Mark W Drummond, Bayard Clarkson, Tessa Holyoake, Franziska Michor
Published 2009-09-01

The probable cell of origin of NF1- and PDGF-driven glioblastomas.

by Dolores Hambardzumyan, Yu-Kang Cheng, Hiroshi Haeno, Eric C Holland, Franziska Michor
Published 2011-01-01

A differentiation-based phylogeny of cancer subtypes.

by Markus Riester, Camille Stephan-Otto Attolini, Robert J Downey, Samuel Singer, Franziska Michor
Published 2010-05-01

Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia.

by Kevin Leder, Jasmine Foo, Brian Skaggs, Mercedes Gorre, Charles L Sawyers, Franziska Michor
Published 2011-01-01

Hidden heterogeneity and circadian-controlled cell fate inferred from single cell lineages

by Shaon Chakrabarti, Andrew L. Paek, Jose Reyes, Kathleen A. Lasick, Galit Lahav, Franziska Michor
Published 2018-12-01

An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer.

by Jasmine Foo, Lin L Liu, Kevin Leder, Markus Riester, Yoh Iwasa, Christoph Lengauer, Franziska Michor
Published 2015-09-01